Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

High-mobility group box-1 contributes tumor angiogenesis under interleukin-8 mediation during gastric cancer progression.

Chung HW, Lim JB.

Cancer Sci. 2017 Aug;108(8):1594-1601. doi: 10.1111/cas.13288. Epub 2017 Jul 7.

2.

Combined targeting of high-mobility group box-1 and interleukin-8 to control micrometastasis potential in gastric cancer.

Chung HW, Jang S, Kim H, Lim JB.

Int J Cancer. 2015 Oct 1;137(7):1598-609. doi: 10.1002/ijc.29539. Epub 2015 Apr 16.

3.

Gastric cancer-derived mesenchymal stem cells prompt gastric cancer progression through secretion of interleukin-8.

Li W, Zhou Y, Yang J, Zhang X, Zhang H, Zhang T, Zhao S, Zheng P, Huo J, Wu H.

J Exp Clin Cancer Res. 2015 May 20;34:52. doi: 10.1186/s13046-015-0172-3.

4.

Xiaotan Sanjie decoction inhibits angiogenesis in gastric cancer through Interleukin-8-linked regulation of the vascular endothelial growth factor pathway.

Shi J, Lu Y, Wei P.

J Ethnopharmacol. 2016 Aug 2;189:230-7. doi: 10.1016/j.jep.2016.05.043. Epub 2016 May 17.

PMID:
27224240
5.

MACC-1 Promotes Endothelium-Dependent Angiogenesis in Gastric Cancer by Activating TWIST1/VEGF-A Signal Pathway.

Wang L, Zhou R, Zhao Y, Dong S, Zhang J, Luo Y, Huang N, Shi M, Bin J, Liao Y, Liao W.

PLoS One. 2016 Jun 9;11(6):e0157137. doi: 10.1371/journal.pone.0157137. eCollection 2016.

6.

[High mobility group box-1 protein activates endothelial cells to produce cytokines and has synergistic effect with lipopolysaccharide in inducing interleukin-6 release].

Liu JH, Li ZJ, Tang J, Liu YW, Zhao L, Deng P, Jiang Y.

Zhonghua Yi Xue Za Zhi. 2006 May 9;86(17):1191-5. Chinese.

PMID:
16796861
7.

Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer.

Gong Z, Ma J, Su H, Guo T, Cai H, Chen Q, Zhao X, Qi J, Du J.

Int J Clin Oncol. 2018 Aug;23(4):659-670. doi: 10.1007/s10147-018-1242-2. Epub 2018 Jan 17.

8.

CEACAM6 promotes tumor angiogenesis and vasculogenic mimicry in gastric cancer via FAK signaling.

Zang M, Zhang Y, Zhang B, Hu L, Li J, Fan Z, Wang H, Su L, Zhu Z, Li C, Yan C, Gu Q, Liu B, Yan M.

Biochim Biophys Acta. 2015 May;1852(5):1020-8. doi: 10.1016/j.bbadis.2015.02.005. Epub 2015 Feb 19.

9.

CHIP functions as a novel suppressor of tumour angiogenesis with prognostic significance in human gastric cancer.

Wang S, Wu X, Zhang J, Chen Y, Xu J, Xia X, He S, Qiang F, Li A, Shu Y, Røe OD, Li G, Zhou JW.

Gut. 2013 Apr;62(4):496-508. doi: 10.1136/gutjnl-2011-301522. Epub 2012 Apr 25.

PMID:
22535373
10.

MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers.

Liu HT, Xing AY, Chen X, Ma RR, Wang YW, Shi DB, Zhang H, Li P, Chen HF, Li YH, Gao P.

Oncotarget. 2015 Nov 10;6(35):37458-70. doi: 10.18632/oncotarget.6059.

11.

Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.

Katkoori VR, Basson MD, Bond VC, Manne U, Bumpers HL.

Oncotarget. 2015 Sep 29;6(29):27763-77. doi: 10.18632/oncotarget.4615.

12.

[High mobility group box-1 stimulates proinflammatory cytokine production in endothelial cells via MAP kinases].

Zhong TY, Tang J, Liu YW, Li ZJ, Chen DY, Zhao MZ, Wang W, Liu JH, Jiang Y.

Nan Fang Yi Ke Da Xue Xue Bao. 2009 Aug;29(8):1517-20. Chinese.

PMID:
19726280
13.

Redox status of high-mobility group box 1 performs a dual role in angiogenesis of colorectal carcinoma.

Zhu L, Ren L, Chen Y, Fang J, Ge Z, Li X.

J Cell Mol Med. 2015 Sep;19(9):2128-35. doi: 10.1111/jcmm.12577. Epub 2015 Jun 23.

14.

High mobility group box 1 is a novel substrate of dipeptidyl peptidase-IV.

Marchetti C, Di Carlo A, Facchiano F, Senatore C, De Cristofaro R, Luzi A, Federici M, Romani M, Napolitano M, Capogrossi MC, Germani A.

Diabetologia. 2012 Jan;55(1):236-44. doi: 10.1007/s00125-011-2213-6. Epub 2011 Jun 8.

PMID:
21656024
15.

RNAi-mediated inhibition of Lgr5 leads to decreased angiogenesis in gastric cancer.

Xi HQ, Zhang KC, Li JY, Cui JX, Gao YH, Wei B, Huang D, Chen L.

Oncotarget. 2017 May 9;8(19):31581-31591. doi: 10.18632/oncotarget.15770.

16.

Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1.

van Beijnum JR, Nowak-Sliwinska P, van den Boezem E, Hautvast P, Buurman WA, Griffioen AW.

Oncogene. 2013 Jan 17;32(3):363-74. doi: 10.1038/onc.2012.49. Epub 2012 Mar 5.

PMID:
22391561
17.

Interaction of coagulation factors and tumor-associated macrophages mediates migration and invasion of gastric cancer.

Ma YY, He XJ, Wang HJ, Xia YJ, Wang SL, Ye ZY, Tao HQ.

Cancer Sci. 2011 Feb;102(2):336-42. doi: 10.1111/j.1349-7006.2010.01795.x. Epub 2010 Dec 7.

18.

Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma.

Huang SP, Wu MS, Shun CT, Wang HP, Lin MT, Kuo ML, Lin JT.

J Biomed Sci. 2004 Jul-Aug;11(4):517-27.

PMID:
15153787
19.

Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer.

Chung HW, Lee SG, Kim H, Hong DJ, Chung JB, Stroncek D, Lim JB.

J Transl Med. 2009 May 28;7:38. doi: 10.1186/1479-5876-7-38.

20.

[Effect of polyunsaturated fatty acids ω-3 and ω-6 on angiogenesis formation in human gastric cancer].

Ma J, Ma Y, Guo T, Chen Q, Li Y, Su H, Chen X, Zhao X, Guo Q, Qi J.

Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Jan 25;20(1):84-89. Chinese.

PMID:
28105626

Supplemental Content

Support Center